{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T00:44:00Z","timestamp":1794617040429,"version":"4.9.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T00:00:00Z","timestamp":1695340800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T00:00:00Z","timestamp":1695340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s10072-023-07078-z","type":"journal-article","created":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T07:01:59Z","timestamp":1695366119000},"page":"507-514","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Treatment modalities for infantile spasms: current considerations and evolving strategies in clinical practice"],"prefix":"10.1007","volume":"45","author":[{"given":"Payton P.","family":"Hollenshead","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrie N.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan V.","family":"Cross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor E.","family":"Witten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed I.","family":"Anwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahab","family":"Ahmadzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4545-4523","authenticated-orcid":false,"given":"Sahar","family":"Shekoohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,22]]},"reference":[{"issue":"10","key":"7078_CR1","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1212\/01.WNL.0000127773.72699.C8","volume":"62","author":"MT Mackay","year":"2004","unstructured":"Mackay MT, Weiss SK, Adams-Webber T et al (2004) Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society. Neurol 62(10):1668\u20131681. https:\/\/doi.org\/10.1212\/01.WNL.0000127773.72699.C8","journal-title":"Neurol"},{"key":"7078_CR2","doi-asserted-by":"publisher","first-page":"107578","DOI":"10.1016\/j.pharmthera.2020.107578","volume":"212","author":"L Vel\u00ed\u0161ek","year":"2020","unstructured":"Vel\u00ed\u0161ek L, Vel\u00ed\u0161kov\u00e1 J (2020) Modeling epileptic spasms during infancy: are we heading for the treatment yet? Pharmacol Ther 212:107578. https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107578","journal-title":"Pharmacol Ther"},{"issue":"4","key":"7078_CR3","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3978\/j.issn.2224-4336.2015.09.01","volume":"4","author":"GR Nelson","year":"2015","unstructured":"Nelson GR (2015) Management of infantile spasms. Transl Pediatr 4(4):260\u2013270. https:\/\/doi.org\/10.3978\/j.issn.2224-4336.2015.09.01","journal-title":"Transl Pediatr"},{"issue":"2","key":"7078_CR4","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1177\/1352458512458844","volume":"19","author":"BG Arnason","year":"2013","unstructured":"Arnason BG, Berkovich R, Catania A, Lisak RP, Zaidi M (2013) Mechanisms of action of adrenocorticotropic hormone and other melanocortins relevant to the clinical management of patients with multiple sclerosis. Mult Scler 19(2):130\u2013136. https:\/\/doi.org\/10.1177\/1352458512458844","journal-title":"Mult Scler"},{"issue":"6","key":"7078_CR5","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1111\/epi.17239","volume":"63","author":"SM Zuberi","year":"2022","unstructured":"Zuberi SM, Wirrell E, Yozawitz E et al (2022) ILAE classification and definition of epilepsy syndromes with onset in neonates and infants: position statement by the ILAE Task Force on Nosology and Definitions. Epilepsia 63(6):1349\u20131397. https:\/\/doi.org\/10.1111\/epi.17239","journal-title":"Epilepsia"},{"issue":"6","key":"7078_CR6","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1055\/a-1909-2977","volume":"53","author":"G Ramantani","year":"2022","unstructured":"Ramantani G, B\u00f6lsterli BK, Alber M et al (2022) Treatment of infantile spasm syndrome: update from the Interdisciplinary Guideline Committee Coordinated by the German-Speaking Society of Neuropediatrics. Neuropediatrics 53(6):389\u2013401. https:\/\/doi.org\/10.1055\/a-1909-2977","journal-title":"Neuropediatrics"},{"issue":"10","key":"7078_CR7","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1111\/j.1528-1167.2010.02657.x","volume":"51","author":"JM Pellock","year":"2010","unstructured":"Pellock JM, Hrachovy R, Shinnar S et al (2010) Infantile spasms: a U.S. consensus report. Epilepsia. 51(10):2175\u20132189. https:\/\/doi.org\/10.1111\/j.1528-1167.2010.02657.x","journal-title":"Epilepsia."},{"issue":"11","key":"7078_CR8","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1111\/j.0013-9580.2004.02404.x","volume":"45","author":"AL Lux","year":"2004","unstructured":"Lux AL, Osborne JP (2004) A proposal for case definitions and outcome measures in studies of infantile spasms and West syndrome: consensus statement of the West Delphi group. Epilepsia 45(11):1416\u20131428. https:\/\/doi.org\/10.1111\/j.0013-9580.2004.02404.x","journal-title":"Epilepsia"},{"key":"7078_CR9","doi-asserted-by":"crossref","unstructured":"Lee S, Jang S, Kim JI, Chae JH, Kim KJ, Lim BC (2022) Whole genomic approach in mutation discovery of infantile spasms patients. Front Neurol:13 Accessed August 9, 2023. https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2022.944905","DOI":"10.3389\/fneur.2022.944905"},{"issue":"12","key":"7078_CR10","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1007\/s10072-020-04600-5","volume":"41","author":"P Pavone","year":"2020","unstructured":"Pavone P, Polizzi A, Marino SD et al (2020) West syndrome: a comprehensive review. Neurol Sci 41(12):3547\u20133562. https:\/\/doi.org\/10.1007\/s10072-020-04600-5","journal-title":"Neurol Sci"},{"issue":"9","key":"7078_CR11","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1093\/brain\/awab162","volume":"144","author":"JD Symonds","year":"2021","unstructured":"Symonds JD, Elliott KS, Shetty J et al (2021) Early childhood epilepsies: epidemiology, classification, aetiology, and socio-economic determinants. Brain 144(9):2879\u20132891. https:\/\/doi.org\/10.1093\/brain\/awab162","journal-title":"Brain"},{"issue":"10","key":"7078_CR12","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S2352-4642(18)30244-X","volume":"2","author":"FJK O\u2019Callaghan","year":"2018","unstructured":"O\u2019Callaghan FJK, Edwards SW, Alber FD et al (2018) Vigabatrin with hormonal treatment versus hormonal treatment alone (ICISS) for infantile spasms: 18-month outcomes of an open-label, randomised controlled trial. Lancet Child Adolescent Health. 2(10):715\u2013725. https:\/\/doi.org\/10.1016\/S2352-4642(18)30244-X","journal-title":"Lancet Child Adolescent Health."},{"issue":"Suppl Suppl 2","key":"7078_CR13","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/epi4.12264","volume":"3","author":"SA Hussain","year":"2018","unstructured":"Hussain SA (2018) Treatment of infantile spasms. Epilepsia Open. 3(Suppl Suppl 2):143\u2013154. https:\/\/doi.org\/10.1002\/epi4.12264","journal-title":"Epilepsia Open."},{"key":"7078_CR14","doi-asserted-by":"publisher","first-page":"135618","DOI":"10.1016\/j.neulet.2020.135618","volume":"746","author":"T Basu","year":"2021","unstructured":"Basu T, Maguire J, Salpekar JA (2021) Hypothalamic-pituitary-adrenal axis targets for the treatment of epilepsy. Neurosci Lett 746:135618. https:\/\/doi.org\/10.1016\/j.neulet.2020.135618","journal-title":"Neurosci Lett"},{"key":"7078_CR15","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0074-7742(02)49013-7","volume":"49","author":"KL Brunson","year":"2002","unstructured":"Brunson KL, Avishai-Eliner S, Baram TZ (2002) ACTH treatment of infantile spasms: mechanisms of its effects in modulation of neuronal excitability. Int Rev Neurobiol 49:185\u2013197","journal-title":"Int Rev Neurobiol"},{"issue":"1","key":"7078_CR16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s42494-020-00025-x","volume":"2","author":"H Yang","year":"2020","unstructured":"Yang H, Yang Z, Peng J et al (2020) Early surgical intervention for structural infantile spasms in two patients under 6\u2009months old: a case report. Acta Epileptol 2(1):16. https:\/\/doi.org\/10.1186\/s42494-020-00025-x","journal-title":"Acta Epileptol"},{"key":"7078_CR17","unstructured":"Acthar-PI.pdf. Accessed April 20, 2023. https:\/\/www.acthar.com\/Static\/pdf\/Acthar-PI.pdf"},{"key":"7078_CR18","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1100\/tsw.2010.173","volume":"10","author":"A Catania","year":"2010","unstructured":"Catania A, Lonati C, Sordi A, Carlin A, Leonardi P, Gatti S (2010) The melanocortin system in control of inflammation. Sci World J 10:1840\u20131853. https:\/\/doi.org\/10.1100\/tsw.2010.173","journal-title":"Sci World J"},{"issue":"5","key":"7078_CR19","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1080\/10799893.2020.1818094","volume":"41","author":"YJ Huang","year":"2021","unstructured":"Huang YJ, Galen K, Zweifel B, Brooks LR, Wright AD (2021) Distinct binding and signaling activity of Acthar Gel compared to other melanocortin receptor agonists. J Recept Signal Transduct 41(5):425\u2013433. https:\/\/doi.org\/10.1080\/10799893.2020.1818094","journal-title":"J Recept Signal Transduct"},{"key":"7078_CR20","doi-asserted-by":"publisher","unstructured":"Mirsaeidi M, Baughman RP, Sahoo D, Tarau E (2023 Published online April 19) Results from a phase 4, multicenter, randomized, double-blind, placebo-controlled study of repository corticotropin injection for the treatment of pulmonary sarcoidosis. Pulm Ther. https:\/\/doi.org\/10.1007\/s41030-023-00222-2","DOI":"10.1007\/s41030-023-00222-2"},{"issue":"8","key":"7078_CR21","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1177\/0961203314531840","volume":"23","author":"D Decker","year":"2014","unstructured":"Decker D, Grant C, Oh L, Becker P, Young D, Jordan S (2014) Immunomodulatory effects of H.P. Acthar Gel on B cell development in the NZB\/W F1 mouse model of systemic lupus erythematosus. Lupus 23(8):802\u2013812. https:\/\/doi.org\/10.1177\/0961203314531840","journal-title":"Lupus"},{"issue":"11","key":"7078_CR22","doi-asserted-by":"publisher","first-page":"813","DOI":"10.2165\/00002018-200124110-00003","volume":"24","author":"R Nabbout","year":"2001","unstructured":"Nabbout R (2001) A risk-benefit assessment of treatments for infantile spasms. Drug Saf 24(11):813\u2013828. https:\/\/doi.org\/10.2165\/00002018-200124110-00003","journal-title":"Drug Saf"},{"key":"7078_CR23","unstructured":"Infantile spasms randomized study Acthar Gel (repository corticotropin injection) Accessed April 23, 2023. https:\/\/actharhcp.com\/clinical-experience\/infantile-spasms\/baram\/#tab3"},{"key":"7078_CR24","doi-asserted-by":"crossref","unstructured":"Bell S, Vincent J, Hammock V et al (2014) A comparison of the safety\/tolerability and pharmacodynamics of acthar gel and methylprednisolone with regimens utilized for the treatment of MS exacerbations (P2.207). Neurol 82(10 Supplement) Accessed April 13, 2023. https:\/\/n.neurology.org\/content\/82\/10_Supplement\/P2.207","DOI":"10.1212\/WNL.82.10_supplement.P2.207"},{"issue":"9","key":"7078_CR25","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1136\/adc.55.9.664","volume":"55","author":"R Riikonen","year":"1980","unstructured":"Riikonen R, Donner M (1980) ACTH therapy in infantile spasms: side effects. Arch Dis Child 55(9):664\u2013672. https:\/\/doi.org\/10.1136\/adc.55.9.664","journal-title":"Arch Dis Child"},{"key":"7078_CR26","unstructured":"Gettig J, Cummings JP, Matuszewski KHP (2009) Acthar gel and cosyntropin review: clinical and financial implications. P T. 34(5):250\u2013257"},{"issue":"8","key":"7078_CR27","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1093\/ndt\/gfu069","volume":"29","author":"MA Hladunewich","year":"2014","unstructured":"Hladunewich MA, Cattran D, Beck LH et al (2014) A pilot study to determine the dose and effectiveness of adrenocorticotrophic hormone (H.P. Acthar\u00ae Gel) in nephrotic syndrome due to idiopathic membranous nephropathy. Nephrol Dial Transplant 29(8):1570\u20131577. https:\/\/doi.org\/10.1093\/ndt\/gfu069","journal-title":"Nephrol Dial Transplant"},{"key":"7078_CR28","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.12688\/f1000research.7192.2","volume":"4","author":"X Li","year":"2016","unstructured":"Li X, Golubovsky J, Hui-Yuen J et al (2016) Adrenocorticotropic hormone gel in the treatment of systemic lupus erythematosus: a retrospective study of patients. F1000Res. 4:1103. https:\/\/doi.org\/10.12688\/f1000research.7192.2","journal-title":"F1000Res."},{"issue":"1","key":"7078_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.36469\/jheor.2021.18727","volume":"8","author":"MS Duchowny","year":"2021","unstructured":"Duchowny MS, Chopra I, Niewoehner J, Wan GJ, Devine B (2021) A Systematic literature review and indirect treatment comparison of efficacy of repository corticotropin injection versus synthetic adrenocorticotropic hormone for infantile spasms. JHEOR 8(1):1\u20139. https:\/\/doi.org\/10.36469\/jheor.2021.18727","journal-title":"JHEOR"},{"key":"7078_CR30","doi-asserted-by":"publisher","first-page":"107786","DOI":"10.1016\/j.yebeh.2021.107786","volume":"116","author":"JT Le","year":"2021","unstructured":"Le JT, Frost JD, Swann JW (2021) Acthar\u00ae Gel (repository corticotropin injection) dose\u2013response relationships in an animal model of epileptic spasms. Epilep Behav 116:107786. https:\/\/doi.org\/10.1016\/j.yebeh.2021.107786","journal-title":"Epilep Behav"},{"key":"7078_CR31","doi-asserted-by":"publisher","unstructured":"Pellock JM, Hrachovy R, Shinnar S, et al. Infantile spasms: A U.S. consensus report:\u00a0Infantile Spasms. Epilepsia. 2010;51(10):2175-2189. https:\/\/doi.org\/10.1111\/j.1528-1167.2010.02657.x","DOI":"10.1111\/j.1528-1167.2010.02657.x"},{"key":"7078_CR32","volume-title":"Vigabatrin","author":"R Singh","year":"2023","unstructured":"Singh R, Carson RP (2023) Vigabatrin, vol 9 Published online January https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK557579\/"},{"issue":"2","key":"7078_CR33","doi-asserted-by":"publisher","first-page":"e57445","DOI":"10.1371\/journal.pone.0057445","volume":"8","author":"B Zhang","year":"2013","unstructured":"Zhang B, McDaniel SS, Rensing NR, Wong M (2013) Vigabatrin inhibits seizures and mTOR pathway activation in a mouse model of tuberous sclerosis complex. PLoS One 8(2):e57445. https:\/\/doi.org\/10.1371\/journal.pone.0057445","journal-title":"PLoS One"},{"issue":"9","key":"7078_CR34","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S1474-4422(22)00213-7","volume":"21","author":"P Curatolo","year":"2022","unstructured":"Curatolo P, Specchio N, Aronica E (2022) Advances in the genetics and neuropathology of tuberous sclerosis complex: edging closer to targeted therapy. Lancet Neurol 21(9):843\u2013856. https:\/\/doi.org\/10.1016\/S1474-4422(22)00213-7","journal-title":"Lancet Neurol"},{"issue":"1","key":"7078_CR35","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S1474-4422(16)30294-0","volume":"16","author":"FJK O\u2019Callaghan","year":"2017","unstructured":"O\u2019Callaghan FJK, Edwards SW, Alber FD et al (2017) Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial. Lancet Neurol 16(1):33\u201342. https:\/\/doi.org\/10.1016\/S1474-4422(16)30294-0","journal-title":"Lancet Neurol"},{"issue":"1","key":"7078_CR36","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/epi.12460","volume":"55","author":"SA Hussain","year":"2014","unstructured":"Hussain SA, Shinnar S, Kwong G et al (2014) Treatment of infantile spasms with very high dose prednisolone before high dose adrenocorticotropic hormone. Epilepsia 55(1):103\u2013107. https:\/\/doi.org\/10.1111\/epi.12460","journal-title":"Epilepsia"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-023-07078-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-023-07078-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-023-07078-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T04:56:56Z","timestamp":1705467416000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-023-07078-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,22]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["7078"],"URL":"https:\/\/doi.org\/10.1007\/s10072-023-07078-z","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,22]]},"assertion":[{"value":"2 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article is based on previously conducted studies and does not contain any\u00a0new studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Guidelines"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}